Indivior (LON:INDV) Shares Up 1.6% – Still a Buy?

Indivior PLC (LON:INDV)’s stock price traded up 1.6% during trading on Wednesday. The stock traded as high as GBX 1,264 and last traded at GBX 1,238. Approximately 8,457,898 shares traded hands during mid-day trading, an increase of 959% from the average session volume of 798,658 shares. The stock had previously closed at GBX 1,219.

Indivior Price Performance

The firm has a 50-day simple moving average of GBX 1,238 and a two-hundred day simple moving average of GBX 1,238. The company has a market capitalization of £1.93 billion, a price-to-earnings ratio of -1,026.48, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.89, a quick ratio of 1.52 and a debt-to-equity ratio of -107.76.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.